BioSpace News Archive

BioMidwest

ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

ANI Pharmaceuticals, Inc. announced the launch of Misoprostol Tablets, 100 mcg and 200 mcg. ANI’s Misoprostol Tablets are the generic version of the Reference Listed Drug Cytotec®.

April 11, 2022
·
3 min read
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines

BioNTech SE and Matinas BioPharma announced that they have entered into an exclusive research collaboration to evaluate the combination of mRNA formats and Matinas’ proprietary LNC platform technology.

April 11, 2022
·
7 min read
Pharm Country

Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development Program

Agile Therapeutics, Inc. announced the receipt of $4.7 million in net proceeds from the sale of tax benefits pursuant to the Company’s participation in the New Jersey Economic Development Authority Net Operating Loss program under the New Jersey Economic Recovery Act of 2020.

April 11, 2022
·
3 min read
Business

TScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance

TScan Therapeutics, Inc. announced the appointment of Leiden Dworak, CPA, MBA, as Vice President, Finance.

April 11, 2022
·
5 min read
Genetown

OncXerna Therapeutics Highlights the Xerna™ TME Panel’s Prognostic and Predictive Value Across Indications and Therapeutic Classes at the AACR Annual Meeting

OncXerna Therapeutics, Inc. (“OncXerna”) is a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapeutic candidates.

April 11, 2022
·
5 min read
Genetown

Cogent Biosciences Presents Nonclinical Data at AACR Annual Meeting and Provides Updates on Portfolio Expansion at R&D Investor Event

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, presented two poster presentations at the American Association of Cancer Research (AACR) annual meeting taking place April 8-13, 2022.

April 11, 2022
·
7 min read
Biotech Bay

PACT Reports New Data on First-of-its-Kind Personalized Neoantigen Platform for Adoptive T Cell Therapies at American Association for Cancer Research (AACR) Annual Meeting 2022

PACT Pharma, Inc. today announced that new data highlighting several aspects of its first-of-its-kind personalized neoantigen platform for adoptive cell therapies were presented in five separate poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022.

April 11, 2022
·
5 min read
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim

Spectrum Pharmaceuticals today announced that the resubmitted Biologics License Application (BLA) for eflapegrastim has been accepted for filing.

April 11, 2022
·
4 min read
Biotech Bay

Circle Pharma Announces Presentation at the American Association for Cancer Research 2022 Annual Meeting

Circle Pharma will present a poster at the American Association for Cancer Research (AACR) Annual Meeting being held April 8-13, in New Orleans, Louisiana.

April 11, 2022
·
2 min read
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D

NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma companies.

April 11, 2022
·
6 min read